UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. Click ...

UiPath CFO and COO Ashim Gupta outlines why the company’s recent progress rests less on agentic AI re-positioning and more on ...

Once thought to be doomed by the AI revolution, robotic process automation specialist UiPath (NYSE: PATH) defied critics in ...

In early January 2026, UiPath Inc. was added to the S&P 1000 and S&P MidCap 400 indices after reporting earnings that ...

With investors' artificial intelligence focus turning to agentic AI, UiPath stock could be a long-term winner.

Company also named a Star Performer by Everest Group in recognition of UiPath’s strong market impact and vision for Continuous Discovery NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leading ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

Early attempts to streamline repetitive front-office tasks often involved macro-driven mouse tricks and screen-scraped regex voodoo. Those brittle solutions were tripped up by the slightest interface ...

NEW YORK--(BUSINESS WIRE)--UiPath, the leading enterprise Robotic Process Automation (RPA) software company, today announced that it has been named a Process Mining Leader in the Technology Vendor ...

NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced that for the fifth consecutive year it has been named a Leader in the Everest ...